Prefrontal activation during inhibitory control measured by near-infrared spectroscopy for differentiating between autism spectrum disorders and attention deficit hyperactivity disorder in adults  by Ishii-Takahashi, Ayaka et al.
NeuroImage: Clinical 4 (2014) 53–63
Contents lists available at ScienceDirect
NeuroImage: Clinical
j ourna l homepage: www.e lsev ie r .com/ locate /yn ic lPrefrontal activation during inhibitory controlmeasured by near-infrared
spectroscopy for differentiating between autism spectrum disorders and
attention deﬁcit hyperactivity disorder in adults☆Ayaka Ishii-Takahashi a,⁎, Ryu Takizawa a, Yukika Nishimura a, Yuki Kawakubo b, Hitoshi Kuwabara b,
Junko Matsubayashi a, Kasumi Hamada a,c, Shiho Okuhata a,d,e,f, Noriaki Yahata a, Takashi Igarashi g,
Shingo Kawasaki g, Hidenori Yamasue a, Nobumasa Kato h, Kiyoto Kasai a, Yukiko Kano b
a Department of Neuropsychiatry Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
b Department of Child Neuropsychiatry Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
c Graduate School of Comprehensive Human Science, Graduate Course of Disability Sciences, University of Tsukuba, Ibaraki, Japan
d Department of Electrical Engineering, Graduate School of Engineering, Kyoto University, Kyoto, Japan
e Japan Society for the Promotion of Science, Tokyo, Japan
f National Center for Child Health and Development, Tokyo, Japan
g Optical Topography Group, Application Development Ofﬁce, Hitachi Medical Corporation, Chiba, Japan
h Karasuyama Hospital, Showa University School of Medicine, Japan☆ This is an open-access article distributed under the t
Attribution-NonCommercial-ShareAlike License, which
distribution, and reproduction in any medium, provided
are credited.
⁎ Corresponding author at: Department of Neurop
Medicine, The University of Tokyo, 7-3-1 Hongo, Bunk
Tel.: +81 3 5800 9263; fax: +81 3 5800 6894.
E-mail address: ayayak-tky@umin.ac.jp (A. Ishii-Takah
2213-1582/$ – see front matter © 2013 The Authors. Pub
http://dx.doi.org/10.1016/j.nicl.2013.10.002a b s t r a c ta r t i c l e i n f oArticle history:
Received 23 June 2013
Received in revised form 2 October 2013
Accepted 3 October 2013
Available online 26 October 2013
Keywords:
Autism spectrum disorders
Attention deﬁcit hyperactivity disorder
Near-infrared spectroscopy
Inhibitory control
Stop signal taskThe differential diagnosis of autism spectrum disorders (ASDs) and attention deﬁcit hyperactivity disorder
(ADHD) based solely on symptomatic and behavioral assessments can be difﬁcult, even for experts. Thus, the de-
velopment of a neuroimagingmarker that differentiates ASDs fromADHDwould be an important contribution to
this ﬁeld. We assessed the differences in prefrontal activation between adults with ASDs and ADHD using an en-
tirely non-invasive and portable neuroimaging tool, near-infrared spectroscopy. This study included 21 drug-
naïve adults with ASDs, 19 drug-naïve adults with ADHD, and 21 healthy subjects matched for age, sex, and IQ.
Oxygenated hemoglobin concentration changes in the prefrontal cortex were assessed during a stop signal
task and a verbal ﬂuency task. During the stop signal task, compared to the control group, the ASDs group exhib-
ited lower activation in a broad prefrontal area, whereas the ADHD group showed underactivation of the right
premotor area, right presupplementary motor area, and bilateral dorsolateral prefrontal cortices. Signiﬁcant dif-
ferenceswere observed in the left ventrolateral prefrontal cortex between the ASDs and ADHD groups during the
stop signal task. The leave-one-out cross-validation method using mean oxygenated hemoglobin changes
yielded a classiﬁcation accuracy of 81.4% during inhibitory control. These results were task speciﬁc, as the
brain activation pattern observed during the verbal ﬂuency task did not differentiate the ASDs and ADHD groups
signiﬁcantly. This study therefore provides evidence of a difference in left ventrolateral prefrontal activation dur-
ing inhibitory control between adultswith ASDs andADHD. Thus, near-infrared spectroscopymay be useful as an
auxiliary tool for the differential diagnosis of such developmental disorders.
© 2013 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction
The differential diagnosis of the 2 commonest types of neuro-
developmental disorders, autism spectrum disorders (ASDs) anderms of the Creative Commons
permits non-commercial use,
the original author and source
sychiatry, Graduate School of
yo-ku, Tokyo 113-8655, Japan.
ashi).
lished by Elsevier Inc. All rights reserattention deﬁcit hyperactivity disorder (ADHD), can be difﬁcult. ASDs
are characterized by impairments in social skills and communication,
as well as repetitive interests and activities (American Psychiatric
Association, 2000; Stigler et al., 2011). ADHD is characterized by
symptoms of inattention, hyperactivity, and impulsivity (American
Psychiatric Association, 2000). These conditions often share symptoms
of inattention, hyperactivity, impulsivity, and neuropsychological
deﬁcits in inhibitory control (Willcutt et al., 2005; Corbett et al., 2009).
Thus, misclassiﬁcation between ASDs and ADHD may occur in clinical
settings, particularly in cases of ASDs with comorbid ADHD symptoms.
Because the clinical symptoms of high-functioning ASDs and ADHD
of adulthood have been modiﬁed according to environmental andved.
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Hofvander et al., 2009; Michielsen et al., 2013), it is more difﬁcult to es-
tablish a differential diagnosis of ASDs and ADHD in adults.
Thesemisclassiﬁcationsmay lead to a suboptimal treatment strategy.
For example, the administration of methylphenidate (MPH), which is a
common treatment for childhood ADHD (Whalen et al., 1989; Barkley
et al., 2005; Newcorn et al., 2008; Jensen et al., 2007), to children with
ASDs and comorbid ADHD symptoms is frequently associated with ad-
verse effects (i.e., social withdrawal, irritability, and stereotypy) severe
enough to warrant treatment discontinuation (Autism Network, 2005;
Di Martino et al., 2004). Despite the insufﬁcient study of the beneﬁts
and adverse effects of MPH in adults with ASDs and ADHD symptoms,
MPH is often administered in these cases, even without evidence of its
efﬁcacy, because it is the ﬁrst line of pharmacological treatment for
adult ADHD (Kooij et al., 2010; Atkinson and Hollis, 2010). Other treat-
ments are more appropriate for adult ASDs, such as selective serotonin
reuptake inhibitors (Williams et al., 2010a), risperidone (McDougle
et al., 1998), and cognitive behavioral therapy (White et al., 2009; Lang
et al., 2010).
The inhibitory dysfunction observed in the two disorders may have
different neurobiological bases, despite similar symptomatic and neuro-
psychological manifestations.
Stop signal and go/no-go tasks are commonly used tasks to detect in-
hibitory control in neuroimaging studies. The stop signal task creates a
higher load on response inhibition processes compared to the go/
no-go task, in that it involves the retraction of a response that has
already been triggered by a go signal (Rubia et al., 2001). Go/no-go
tasks have a higher load on response selection, due to the a priori
knowledge about whether or not to respond to the presentation of spe-
ciﬁc categorical stimuli (Rubia et al., 2001).
Studies of children with ASDs have revealed no signiﬁcant differ-
ences compared to healthy children in the stop signal task (Ozonoff
and Strayer, 1997) but lower performance in the go/no-go task
(Happé et al., 2006). Inhibitory motor control as assessed by the stop
signal task has been studied extensively in ADHD. Themeta-analysis re-
vealed a signiﬁcant difference in stop latency (stop signal reaction time)
between ADHD patients and matched controls in both children and
adults (Lijfﬁjt et al., 2005), while children with ADHD had lower perfor-
mance compared to healthy controls in the go/no-go task (Happé et al.,
2006; Raymaekers et al., 2007).
Most previous neuropsychological and neuroimaging studies
comparing ADHDwith ASDswere performed in children. Neuropsycho-
logical studies have found that the ASDs group can have either better
(Ozonoff and Jensen, 1999; Geurts et al., 2004; Happé et al., 2006) or
poorer (Corbett et al., 2009) inhibitory control than the ADHD group.
However, some studies showed little difference in executive function
proﬁles between ADHD and ASDs (Goldberg et al., 2005; Verté et al.,
2006). The only neuropsychological study performed in adult patients
revealed signiﬁcant differences between ADHD and ASDs in the Stroop
task. However, using the Hayling Sentence Completion Test, which as-
sesses verbal response inhibition, it was found that adults with ADHD
did not exhibit more severe impairments compared to those with
ASDs (Johnston et al., 2011).
Thus, the development of an inhibitory-task-related neurophysio-
logical index as an auxiliary tool for the differential diagnosis of ASDs
and ADHD in adults would be an important contribution to this ﬁeld.
Recent functional magnetic resonance imaging (fMRI) and event-
related potential studies have revealed differences between children
with ASDs and ADHD (Christakou et al., 2012; Malisza et al., 2011;
Kemner et al., 1995; Groen et al., 2008). To date, however, no studies
have directly compared adults with ASDs to those with ADHD using
functional neuroimaging or neurophysiological indices.
Ideally, a diagnostic index should be developed using a neuroimaging
tool that is suitable for application in clinical settings. Near-infrared
spectroscopy (NIRS) is an optical neuroimaging technique that allows
the non-invasive measurement of changes in the concentrations ofoxygenated and deoxygenated hemoglobin ([oxy-Hb] and [deoxy-Hb],
respectively), thus reﬂecting regional cerebral blood volume (Hoshi
and Tamura, 1993; Villringer et al., 1993). NIRS is safe and portable
and allows the examination of subjects in a natural sitting position. The
resolution of NIRS for detecting time-course alterations in brain activa-
tion in the prefrontal cortex (PFC) is ﬁner than that of fMRI. Therefore,
NIRS could be applied as an auxiliary diagnosis tool in clinical psychiatry.
Our research aim was to determine whether prefrontal NIRS signals
recorded during an inhibitory control task differed between adults with
ASDs and those with ADHD. In this study, we used a stop signal task
(SST) to detect brain activation associated with inhibitory control. We
chose the letter version of the verbal ﬂuency task (VFT) as a control
index of prefrontal function to test whether the ﬁndings were task spe-
ciﬁc. We hypothesized that adults with ASDs and ADHD would exhibit
differential prefrontal NIRS signals during the SST, and that both groups
of patients would show activation of the PFC compared to the control
group. Further, we hypothesized that during the VFT, both groups
would show a similarly reduced activation of the PFC compared to the
control group.
2. Materials and methods
2.1. Participants
Twenty-one adults with ASDs, 19 adults with ADHD, and 21 healthy
control (HC) subjects participated in the study (Table 1). We recruited
26 adultswith ASDs and 25 adults with ADHD from the outpatient clinic
at the Department of Neuropsychiatry, University of Tokyo Hospital,
Japan, and from community clinics. After recruitment of the patient
group, some individuals were recruited in the control group in order
to match patients for age, sex, and IQ. As a result, all participating sub-
jects werematched for age, sex, and IQ (Table 1). All subjects gavewrit-
ten informed consent in accordance with the Declaration of Helsinki
after a complete explanation of the study. The ethics committee of
the University of Tokyo Hospital approved this study (approval no.:
630-6). The diagnoses of ASDs and ADHD were established in accor-
dance with the Diagnostic and Statistical Manual of Mental Disorders,
4th edition (DSM-IV) based on comprehensive clinical assessments
performed by at least 2 trained child psychiatrists (YK, HK, and AI).
We included participants in this study only when at least 2 of the 3
child psychiatrists had seen patients and given consistent diagnoses.
Current and lifetime DSM-IV diagnoses, other than ASDs/ADHD, were
ruled out based on a consensus decision using information gained
from independent clinical interviews, other available clinical data, and
from theMini-International Neuropsychiatric Interview (MINI). The ex-
clusion criteria for all groups were as follows: full-scale IQ b70, neuro-
logical illness, genetic disorders, traumatic brain injury with any
known cognitive consequences or loss of consciousness for more than
5 min, a history of electroconvulsive therapy, a history of treatment
with stimulants or other psychiatric medication, alcohol/substance
abuse or addiction, bipolar disorder, and schizophrenia. An additional
exclusion criterion for the control group was personal history of a psy-
chiatric disease, as assessed using theMINI, or a family history of psychi-
atric disease among their ﬁrst-degree relatives.
None of the adults with ASDs or ADHD had been treated with stim-
ulants or other psychiatric medication. In Japan, MPH was approved
only for treatment of children with ADHD in 2007, and it cannot be
used for treating adult ADHD in Japan. Therefore, MPH cannot be used
even for cases with severe ADHD symptoms.
The HC group was also free of medication. To the extent possible, we
obtained childhood information from a person who knew the patient in
childhood (usually the mother). At the time of the recruitment of the
subjects, the usage of the Autism Diagnostic Interview, Revised (ADI-R),
Autism Diagnostic Observation Schedule (ADOS), and Conners' Adult
ADHD Diagnostic Interview for DSM-IV™ (CAADID) was extremely lim-
ited in Japan. Before we ﬁnished recruitment, we obtained permission
Table 1








Mean (SD) Mean (SD) Mean (SD) P Post-hoc P
ASDs:HC ADHD:HC ASDs:ADHD
Age, years 30.8 (7.2) 30.6 (7.4) 28.8 (5.5) 0.60
Sex, men/women 8 13 11 8 13 8 0.26
IQ 105.1 (14.6) 102.6 (16.6) 109.0 (5.6) 0.25
SST (all trials), % 80.8 (11.6) 78.9 (13.8) 84.9 (9.3) 0.26
SST (stop trials), % 49.2 (38.4) 56.1 (26.3) 65.6 (23.6) 0.22
SST (go trials), % 94.3 (7.2) 87.7 (20.2) 92.7 (9.8) 0.27
MRT (SST), ms 498.0 (102.7) 539.1 (100.4) 558.1 (75.8) 0.11
VFT, words 16.0 (4.3) 15.5 (4.5) 16.9 (4.4) 0.60
ASRS 3.2 (1.8) 5.2 (0.8) 1.3 (1.1) b0.01 b0.01 b0.01 b0.01
WURS 53.1 (23.2) 62.1 (20.0) 17.5 (9.3) b0.01 b0.01 b0.01 0.39
AQ total score 33.5 (7.9) 27.6 (5.5) 13.4 (4.2) b0.01 b0.01 b0.01 0.02
GAF 51.8 (13.2) 58.8 (10.7) 84.6 (3.1) b0.01 b0.01 b0.01 0.45
Subtype Asperger, 5; PDD NOS, 16 ADHD, 11; ADD, 8
ASDs, autism spectrum disorders; ADHD, attention deﬁcit hyperactivity disorder; HC, healthy control subjects; Asperger, Asperger syndrome; PDD, pervasive developmental disorder;
NOS, pervasive developmental disorder - not otherwise speciﬁed; IQ, intelligence quotient; SST, stop signal task; MRT, mean reaction time; VFT, verbal ﬂuency task; ASRS, The World
Health Organization (WHO) Adult ADHD Inhibitory-Report Scale; WURS, Wender Utah Rating Scale; AQ, autism spectrum quotient; GAF, Global Assessment of Functioning.
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psychiatrists and psychologists (HK, YK, and AI) to 6 participants (3 ASDs
and 3 ADHD participants). The conventional diagnosis was coincident
with the diagnosis obtained using ADI-R, ADOS, and CAADID in these 6
participants.
All participants were self-reported right-handers, as assessed using
the Edinburgh score (N70) (Oldﬁeld, 1971). The IQ scores of subjects
with ASDs and ADHD were obtained using the Wechsler Adult Intelli-
gence Scale-Revised (WAIS-R), Japanese version. The IQ scores of the
HCs were estimated using the Japanese version of the National Adult
Reading Test (JART) (Matsuoka et al., 2006). Although the JART can
measure IQ accurately in HCparticipants, the test is problematic for par-
ticipants with ASDs and ADHD because of the well-known imbalances
in their intellectual abilities.
A self-reported screening scalewas used to assess ADHD symptoms;
the World Health Organization (WHO) Adult ADHD Self-Report Scale
(ASRS), which was developed in conjunction with the revision of the
WHO Composite International Diagnostic Interview (CIDI) (cutoff N3).
The Japanese version of the Wender Utah Rating Scale (WURS), which
is a self-reporting instrument that is used to identify childhood tenden-
cies toward ADHD retrospectively (cutoff N46) (Matsumoto et al.,
2005), was also used. We used these 2 scales in the ASDs and ADHD
groups.
We applied the Autism Spectrum Quotient (AQ), as obtained from a
self-reported questionnaire, to quantify autistic symptoms in all partic-
ipants (Baron-Cohen et al., 2001; Wakabayashi et al., 2006). The AQ
comprises 50 questions, with 10 questions assessing each of 5 different
areas: social skills, attention switching, attention to detail, communica-
tion, and imagination. Scores range from 0 to 50 (cutoff N32).
2.2. Task procedure
Hemoglobin concentration ([Hb]) changes were measured during 2
cognitive activation tasks. Subjects sat on a comfortable chair with their
eyes open throughout the NIRS measurements and were instructed to
minimize movements such as head movements, strong biting, and eye
blinking. The sequence of the following 2 tasks was counterbalanced
across the subjects.
2.2.1. SST
The cognitive activation task included a 30 s pre-SST, an 81 s SST,
and an 80 s post-SST period (Fig. 1A). We selected the block design
for the cognitive activation task. In the pre- and post-SST periods
(Fig. 1B), the participants were instructed to indicate the direction ofan image of a dog (left or right) by pressing a button as quickly as
possible. Participants performed 20 trials during the pre-task period
and 30 trials during the post-task period. The mean reaction time was
calculated automatically during the pre-task period. The image of a
dog was displayed for 0.5 s. Between presentation of the images of
dogs, a cross shape was shown for 0.4–1.0 s.
During the SST (Fig. 1C), participants were instructed to respond to
the “GO” stimulus as quickly as possible during the “GO” trials, and to
try to withhold their response on the “STOP” trials (short beep).
“STOP” signals were given under 3 conditions of delay after the “GO”
stimulus was presented (ΔT equal to mean reaction time [MRT], MRT
— 100 ms, and MRT — 250 ms). We used these 3 conditions of delay
to avoid the usual tendency to delay the Go response. The subjects per-
formed 21 “GO” trials and 9 “STOP” trials during the SST. We used the
total number of correct responses (the number of correct inhibitions
plus the number of correct responses to the direction of the dog) divid-
ed by the total number of trials as a measure of task performance. We
also used the success rate of stop trials and go trials in SST period as a
measure of task performance.
2.2.2. VFT
The VFT, which was presented as described previously (Takizawa
et al., 2008, 2009), included a 30 s pre-VFT, a 60 s VFT (letter version),
and a 70 s post-VFT period. In the pre- and post-task baseline periods,
the subjects were instructed to repeat Japanese vowels (/a/, /i/, /u/, /e/,
and /o/) aloud. This was intended to correct the data during the ﬂuency
task with regard to activation due to vocalization. During the VFT peri-
od, participants were instructed to generate as many Japanese words
beginning with a designated syllable as possible. This approach is com-
monly used in the Japanese letter version of the VFT, as Japanese words
inevitably beginwith a vowel or a consonant–vowel syllable. The 3 initial
syllables (ﬁrst: /to/, /a/, or /na/; second: /i/, /ki/, or /se/; third: /ta/, /o/, or /
ha/) were presented in an order that was counterbalanced among the
subjects and changed every 20 s during the 60 s task period, to reduce
the time during which the subjects remained silent. The subjects were
instructed by an auditory cue at the start and end of the task and when
the syllable was changed. The total number of correct words generated
during the 60 s activation period was used as a measure of task
performance.
2.3. NIRS measurement
Relative [oxy-Hb] and [deoxy-Hb] changes were monitored using a
52-channel NIRS machine (Hitachi ETG-4000) at 2 wavelengths of
Fig. 1. Schematic representation of the stop signal task. Auditory “STOP” signals were given under 3 conditions of delay (ΔT equal to the mean reaction time [MRT], MRT— 100 ms, and
MRT — 250 ms) after the “GO” stimulus was presented.
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Lambert law. The distance between pairs of light source and detector
probes was set at 3 cm, and each measurement area between pairs of
source/detector probes was deﬁned as a “channel.” The probes of the
NIRSmachine were arranged in 3 × 11 shells and placed on the subject's
frontal area. The lowest probes were positioned along the T3–Fpz–T4
line, according to the international 10/20 system. As described previous-
ly (Takizawa et al., 2008), this arrangement of the probes is able to detect
[Hb] changes in the surface regions of the PFC on bilateral sides (dorso-
lateral PFC [DLPFC; Brodmann areas (BA) 9 and 46], ventrolateral PFC
[VLPFC; BA44, 45, and 47], and frontopolar PFC [; BA10]), and the tempo-
ral cortex. To estimate the cortical localization of each channel, we used
the virtual registration method (Tsuzuki et al., 2007; Tzourio-Mazoyer
et al., 2002), which enables the probabilistic registration of NIRS data
onto the Montreal Neurological Institute (MNI) coordinate space with-
out data on magnetic resonance images or probe positions (Fig. 2).
The sampling rate was set to 10 Hz. The pre-task period value was
determined as the mean value over a 10 s period just prior to the taskFig. 2. Locations of thenear-infrared spectroscopy (NIRS) probes. The locations ofNIRSmeasurem
brain space (LBPA40) according to Tsuzuki et al. (2007).period, and the post-task period value was determined as the mean
value over the last 10 s of the post-task period. Linear ﬁtting was per-
formed using data from the pre- and post-task periods. The moving av-
erage method was used to remove any short-term motion artifacts
(moving average window, 5 s). The time resolution of the NIRS appara-
tuswas set at 0.1 s and changeswere analyzed using the ﬁrst-order cor-
rection to exclude changes unrelated to the task, such as very slow
oscillations or baseline drifts. To acquire a stable baseline, a 20 s non-
measured period was included in the 30 s pre-task period; NIRS mea-
surement started in the last 10 s of the pre-task period. Because the
NIRS signal was sometimes unstable at the start of the pre-task period,
the pre-task baseline was determined as the mean across the last 10 s
of the this period, the post-task baseline was determined as the mean
across the last 10 s of the post-task period, and a linear ﬁtting was per-
formed on the basis of data between the 2 baselines according to previ-
ous NIRS studies (Takizawa et al., 2008; Marumo et al., 2013).
Despite the application of these artifact-rejection methods, visible
artifacts sometimes remained in the waveforms. We therefore used aents (channels)were estimated probabilistically and labeled anatomically in the standard
Fig. 3. Time courses of the hemodynamic responses in the left ventrolateral prefrontal cor-
tex (ch50) for the 3 diagnostic groups. The [oxy-Hb] changes for the healthy control (HC)
group (black, n = 21), attention deﬁcit hyperactivity disorder (ADHD) group (pink,
n = 19), and autism spectrum disorders (ASDs) group (blue, n = 21) during the activa-
tion stop signal task (SST) andpost-SST conditions are presented as grand-averagedwave-
forms in ch50. The shaded color indicates the standard deviation.
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that automatically rejected channels that included waveforms with
prominent artifacts. Because we excluded the rejected channels from
further analyses, the number of available channels varied among
individuals.
Finally, the [oxy-Hb] and [deoxy-Hb] data obtained for each channel
were averaged for the task period and the [task + post-task] period, re-
spectively. We chose these 2 NIRS signals to detect the time course of
[oxy-Hb] and [deoxy-Hb] changes during cognitive tasks.
2.4. Statistical analyses
All statistical analyses were performed using the Statistical Package
for the Social Sciences (SPSS) 18 software (SPSS Inc., Tokyo, Japan).
2.4.1. Clinical scale and task performance
Between-group differences in the scores for clinical scales and task
performance were tested using a 1-way analysis of variance (ANOVA)
and Tukey's honestly signiﬁcant difference (HSD) test as a post-hoc
analysis. A chi-squared test was used for testing sex differences. Clinical
and behavioral results were considered signiﬁcant at P b 0.05.
2.4.2. NIRS data
We focused on the mean [oxy-Hb], as the [oxy-Hb] increase is as-
sumed to reﬂect cognitive activation more directly than does the
[deoxy-Hb] decrease, as shown by a stronger correlation of [oxy-Hb]
with the blood-oxygenation-level-dependent signal measured by fMRI
(Strangman et al., 2002) and by results of animal studies (Hoshi et al.,
2001).
For the SST and VFT, mean [oxy-Hb] values were analyzed via one-
way ANOVA using the mean [oxy-Hb] as the dependent variable and
the diagnosis (ASDs, ADHD, or HC) as the independent variable for
each period (the task period or the [task + post-task] period) and for
each channel. A false-discovery rate (FDR) correction for multiple com-
parisons (52 channels) was applied. We set the value for themaximum
FDR to 0.05, to allow nomore than 5% false positives on average (Singh
and Dan, 2006). The mean [oxy-Hb] values were then analyzed using
Tukey's HSD test, as a post-hoc analysis, for each period and for each
channel.
2.4.3. Classiﬁcation and cross-validation
The individual expression valueswere deﬁned as themean [oxy-Hb]
values during the task (or task + post-task) period. We submitted the
resulting individual expression values to a parametric Fisher's linear dis-
criminant analysis classiﬁcation algorithm (Ponseti et al., 2012) in order
to discriminate the ASDs from the ADHD group, the ASDs from the HC
group, and the ADHD from the HC group.
First, we used stepwise analysis for all channels that showed a signif-
icant difference (P b 0.05) between the ASDs and ADHD group, the ASDs
and HC group, or the ADHD and HC group to select the channels to be
used in Fisher's linear discriminant analysis. A stepwise analysiswas per-
formed in a forward direction using P values for entry (P = 0.05) and re-
moval (P = 0.10).
Second, we classiﬁed each participant according to these values
using Fisher's linear discriminant analysis.We cross validated the classi-
ﬁcation method using a leave-one-out procedure 40–42 times, to ac-
count for each participant. We determined the predictive power of the
classiﬁcation procedure by calculating speciﬁcity and sensitivity, as
well as average sensitivity and speciﬁcity values andmean classiﬁcation
accuracy.
2.4.4. Additional analyses
We evaluated whether [deoxy-Hb] changes had tendencies similar
to the [oxy-Hb] changes among the 3 groups, although, overall, we
focused on [oxy-Hb] changes. We also addressed prefrontal [oxy-Hb]
changes in ASDs adults with ADHD symptoms, who are difﬁcult todifferentiate clinically from ADHD adults. We deﬁned a subgroup of
ASDs adults who exceeded the ASRS cutoff (N3) (n = 10). A different
activation between participants with a diagnosis of ASDs who also had
ADHD symptoms and the ADHD group would represent an ASDs-
speciﬁc brain dysfunction. The 3 diagnostic groups (the ASDs subgroup
with ADHD symptoms, the entire ADHD group, and the entire HC
group) were then compared using the statistical procedures described
above. Furthermore, we compared [oxy-Hb] changes between male
and female subjects in each group, because a previous NIRS study dem-
onstrated that [oxy-Hb] changes were affected by sex (Kameyama et al.,
2004). In addition, we performed a correlation analysis to examine the
relationship between [oxy-Hb] changes and clinical conditions and de-
mographic data, such as age, symptom severity, and task performance.
3. Results
3.1. Clinical characteristics and behavioral results
All patients with ADHD and 10 patients with ASDs exceeded the cut-
off of the ASRS (Table 1). The ASRS scores of all HC subjects were below
the cutoff value. The mean WURS scores of the patients exceeded the
threshold (N46), suggesting a difﬁculty in distinguishing these 2 disor-
ders based on retrospective inhibitory-reporting assessments in their
childhood. The ASDs group had signiﬁcantly higher AQ scores than did
the other groups. No statistically signiﬁcant differences were observed
among the 3 groups in any of the task-performance indices.
3.2. NIRS data results
3.2.1. SST
The typical grand-averagedwaveforms for [oxy-Hb] in the left VLPFC
(ch50) in theHC, ASDs, andADHDgroups are shown in Fig. 3. During the
SST period, we found signiﬁcantmain effects of the group in 29 channels
(ch1–3, 10–13, 18, 20, 22, 24, 28, 29, 31, 32, 35–39, 41, 42, and 45–51; F
[df = 2, 53–58] = 3.911–15.448; FDR-corrected P ≤ 0.001–0.026).
The [oxy-Hb] changes in the ASDs group were signiﬁcantly smaller
than those in the ADHD group in 2 channels corresponding to the left
VLPFC (ch50 and 51; post-hoc P = 0.030–0.034) (Figs. 3 and 4, see
Inline Supplementary Table S1). Tukey's HSD test indicated that [oxy-
Hb] changes in the ASDs group were signiﬁcantly smaller than those
in the HC group in 28 channels corresponding to the bilateral DLPFC,
left VLPFC, left premotor area (PMA), left presupplementary motor
area (SMA), and frontal pole (ch2, 3, 10–13, 18, 20, 22, 24, 28, 29, 31,
Fig. 4.Differences in [oxy-Hb] changes during the SST between theHC and ADHD groups (A), between theHC and ASDs groups (B), and between the ASDs and ADHD groups (C) (A: post-
hoc P ≤ 0.001–0.046; B: post-hoc P = 0.001–0.047: and C: post-hoc P = 0.030–0.034). The colored bar represents the P value.
58 A. Ishii-Takahashi et al. / NeuroImage: Clinical 4 (2014) 53–6332, 35–39, 41, 42, and 45–51; post-hoc P ≤ 0.001–0.046) (Figs. 3 and 4,
see Inline Supplementary Table S1). [oxy-Hb] changes in the ADHD
group were signiﬁcantly smaller than those in the HC group in 17
channels corresponding to the frontal pole, the bilateral DLPFC, the
right PMA, and the right pre-SMA (ch1–3, 11–13, 18, 22, 28, 29, 36,
38, 39, and 46–49; post-hoc P = 0.001–0.047) (Fig. 4, see Inline Supple-
mentary Table S1).
Inline Supplementary Table S1 can be found online at http://dx.doi.
org/10.1016/j.nicl.2013.10.002.
During the [SST + post-SST] period, there was a main effect of the
group in 31 channels (ch2, 3, 8–10, 12, 13, 18, 20, 24, 26–31, 35–39,
41, 42, and 45–52; F [df = 2, 53–58] = 4.291–12.721; FDR-corrected
P ≤ 0.001–0.019).
The [oxy-Hb] increases observed in the ADHD group were signiﬁ-
cantly larger than those recorded in the ASDs group in 5 channels corre-
sponding to the left VLPFC and frontal pole (ch24, 30, 41, 50, and 51;
post-hoc P = 0.003–0.046) (Figs. 3 and 5, Supplementary Table A. 2).
The number of channels that exhibited signiﬁcantly different NIRS
signals between the ASDs and ADHD groups were larger for the
[SST + post SST] analysis than that for the SST analysis, which was
mainly driven by a post-SST reascending in [oxy-Hb] in the ADHD
group (Fig. 3). The post-hoc Tukey's HSD test revealed that the [oxy-Hb] increases observed during the [SST + post-SST] period in the
ASDs group were signiﬁcantly smaller than those in the HC group in
31 channels corresponding to the bilateral DLPFC, bilateral VLPFC, bilat-
eral PMA, bilateral pre-SMA, and frontal pole (ch2, 3, 8–10, 12, 13, 18,
20, 24, 26–31, 35–39, 41, 42, and 45–52; post-hoc P ≤ 0.001–0.033)
(Figs. 3 and 5, see Inline Supplementary Table S2). The [oxy-Hb] in-
creases observed in the ADHD group were signiﬁcantly smaller than
those in the HC group in 11 channels corresponding to the frontal
pole, bilateral DLPFC, right PMA, and right pre-SMA (ch3, 13, 27, 28,
35, 38, 39, and 46–49; post-hoc P = 0.005–0.046) (Fig. 5, see Inline
Supplementary Table S2).
Inline Supplementary Table S2 can be found online at http://dx.doi.
org/10.1016/j.nicl.2013.10.002.3.2.2. VFT
During the VFT period, we found no signiﬁcant main effects of
the group. There were no signiﬁcant differences in [oxy-Hb] changes
between the ASDs and ADHD groups during the VFT. During the
[VFT + post-VFT] period, we found signiﬁcant main effects of the
group in 2 channels (ch13 and 34; F [df = 2, 51–55] = 7.277–8.056;
FDR-corrected P = 0.001–0.002).
Fig. 5.Differences in [oxy-Hb] changes during the [SST + post-SST] period between the HC and ADHD groups (A), between the HC and ASDs groups (B), and between the ASDs andADHD
groups (C) (A: post-hoc P ≤ 0.001–0.033; B: post-hoc P = 0.005–0.046; and C: post-hoc P = 0.003–0.046). The colored bar represents the P value.
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ASDs and ADHD groups during the [VFT + post-VFT] period. Post-hoc
Tukey's HSD tests showed that the [oxy-Hb] changes in the ASDs
group were signiﬁcantly smaller than those in the HC group in 2 chan-
nels corresponding to the left VLPFC and DLPFC (ch13 and 34; post-
hoc P = 0.002–0.003) during the [VFT + post-VFT] period. The [oxy-
Hb] changes in the ADHD group were signiﬁcantly smaller than those
recorded in the HC group in 2 channels corresponding to the left
VLPFC and DLPFC (ch13 and 34; post-hoc P = 0.004–0.019) during
the [VFT + post-VFT] period.3.3. Classiﬁcation and cross-validation
3.3.1. Discrimination between the ASDs and ADHD groups
ANOVA revealed the presence of signiﬁcant differences between pa-
tients with ASDs and those with ADHD in the left VLPFC. Individual
brain responses were characterized by expression values in 2 channels
with signiﬁcant differences in themean [oxy-Hb] during the SST period
between ASDs and ADHD adults (ch50 and 51). The stepwise analysis
selected 1 channel (ch50: left VLPFC) using the mean [oxy-Hb] during
the SST period (P = 0.02). The leave-one-out classiﬁcation algorithmusing the mean [oxy-Hb] during the SST period had an accuracy of
72.9% (sensitivity, 85.7%; speciﬁcity, 57.9%).
Individual brain responses were characterized by expression values
in 5 channels with signiﬁcant differences in the mean [oxy-Hb] during
the [SST + post-SST] period between adults with ASDs and those
with ADHD (ch24, 30, 41, 50, and 51). The stepwise regression analysis
selected 1 channel (ch30: left VLPFC) using the mean [oxy-Hb] during
the [SST + post-SST] period (P = 0.002). The algorithm that used the
mean [oxy-Hb] during the [SST + post-SST] period had high accuracy
(81.4%; sensitivity, 90.0%; speciﬁcity, 70.6%).3.3.2. Discrimination of the ASDs from the HC group
ANOVA revealed the presence of signiﬁcant differences between pa-
tients with ASDs and HC individuals in the broad prefrontal area. Indi-
vidual brain responses were characterized by expression values in 34
channels that were signiﬁcantly different regarding the mean [oxy-Hb]
during the SST period between patients with ASDs and healthy adults
(ch2, 3, 7–13, 17, 18, 20, 22, 24, 28, 29, 31, 32, 35–39, 41, 42, and
45–52). The stepwise regression analysis selected 1 channel (ch39: left
VLPFC) using the mean [oxy-Hb] during the SST period (P b 0.001).
The leave-one-out classiﬁcation algorithm had an accuracy of 81.1%
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the SST period.
Individual brain responses were characterized by expression values
in 36 channels that showed signiﬁcant differences in themean [oxy-Hb]
during the [SST + post-SST] period between patients with ASDs and
healthy adults (ch2, 3, 7–10, 12, 13, 18–20, 24–32, 35–39, 41, 42, and
45–52). The stepwise regression analysis selected 2 channels (ch47
and 50: frontal pole and left VLPFC) using the mean [oxy-Hb] during
the [SST + post-SST] period (P b 0.001). The algorithm that used the
mean [oxy-Hb] during the [SST + post-SST] period had high accuracy
(89%; sensitivity, 90.0%; speciﬁcity, 80.0%).
3.3.3. Discrimination of the ADHD from the HC group
ANOVA revealed the presence of signiﬁcant differences between pa-
tients with ADHD and HC individuals in the right pre-SMA, right PMA,
and bilateral DLPFC. Individual brain responses were characterized by
expression values in 17 channels with signiﬁcant differences in the
mean [oxy-Hb] during the SST period between patients with ADHD
and healthy adults (ch1–3, 11–13, 18, 22, 28, 29, 36, 38, 39, and
46–49). The stepwise regression analysis selected 1 channel (ch11:
right pre-SMA and right PMA) using the mean [oxy-Hb] during the
SST period. The leave-one-out classiﬁcation algorithm using the mean
[oxy-Hb] during the SST period had a mean accuracy of 78.8% (sensitiv-
ity, 84.2%; speciﬁcity, 76.2%).
Individual brain responses were characterized by expression values
in 11 channels with signiﬁcant differences in themean [oxy-Hb] during
the [SST + post-SST] period between patients with ADHD and healthy
adults (ch3, 13, 27, 28, 35, 38, 39, and 46–49).
The stepwise regression analysis selected 1 channel (ch13: right pre-
SMA and right PMA) using the mean [oxy-Hb] during the [SST+post-
SST] period (P = 0.006). The algorithm that used the mean [oxy-Hb]
during the [SST + post-SST] period had a mean accuracy of 72.5%
(sensitivity, 72.2%; speciﬁcity, 71.4%).
3.3.4. Additional analyses
There were no signiﬁcant main effects in the results obtained for
[deoxy-Hb] during the task or the [task + post-task] period, for either
the SST or VFT tasks (see inline Supplementary material A. 2). In addi-
tion, the secondary group comparison (the ASDs subgroup with ADHD
symptoms, the entire ADHD group, and the entire HC group) yielded
statistical conclusions regarding clinical characteristics, behavioral re-
sults, and NIRS data results that were similar to those of the original
group comparisons (see Inline Supplementary Table S3 and Supple-
mentary material A. 3). There were no signiﬁcant differences in
NIRS data between male and female subjects during the task or the
[task + post-task] period. Finally, for both the SST and VFT, there
were no signiﬁcant correlations between [oxy-Hb] changes during the
task or the [task + post-task] period and clinical symptoms or task per-
formance for either the ASDs or the ADHD group.
Inline Supplementary Table S3 can be found online at http://dx.doi.
org/10.1016/j.nicl.2013.10.002.
4. Discussion
To our knowledge, this is the ﬁrst study showing differences in pre-
frontal activation associated with inhibitory control between adults
with ASDs and those with ADHD. We found more profound abnormali-
ties in the PFC during inhibitory control in drug-naïve individuals with
ASDs than in drug-naïve individuals with ADHD, despite similar perfor-
mance levels. Although the ASDs group showed underactivation in the
left VLPFC compared to the HC group, the ADHD group did not exhibit
a signiﬁcant decrease in VLPFC activation compared to theHC group. Sig-
niﬁcant differences between the ASDs and ADHD groups were found
during the SST, even in comparisons between the ASDs subgroup with
ADHD symptoms and the ADHD group. These differences in activation
were localized to the left VLPFC. In contrast, there were no signiﬁcantdifferences in [oxy-Hb] increases during the VFT between the ASDs and
ADHD groups. The use of NIRS, a portable neuroimaging device, repre-
sented a strong advantage of our study. Therefore, our ﬁndings may be
a step toward the development of a clinically useful biomarker for the
differential diagnosis of the 2 commonest neurodevelopmental disor-
ders, which has been difﬁcult when based on clinical and neuropsycho-
logical measures.4.1. Activation of [Oxy-Hb] in the left VLPFC
This study found signiﬁcantly reduced activation in the left VLPFC in
drug-naïve adults with ASDs compared to drug-naïve adultswith ADHD
(Figs. 4 and 5), which is consistent with the previously reported struc-
tural abnormalities in the left VLPFC of patients with ASDs, including
reduced gray matter density (Yamasaki et al., 2010; Abell et al., 1999).
The right dominant abnormalities observed in the ADHD group were
consistent with the results of previous structural (Makris et al., 2007;
Overmeyer et al., 2001) and fMRI studies performed during go/no-go
(Casey et al., 2007) and stop tasks (Rubia et al., 1999; Hart et al.,
2013). Our ﬁndings are also consistent with the results of fMRI studies
showing dysfunction in this region during facial imitation (Dapretto
et al., 2006; Bookheimer et al., 2008). Actionmirroring is assumed to un-
derlie the imitation of an observed action, social understanding, and
communication with other people, and the mirroring system is a func-
tion of the VLPFC (Dapretto et al., 2006).
The reduced [oxy-Hb] increase observed in the left VLPFC of the
ASDs group was inconsistent with the results of previous studies
showing increased activation (Schmitz et al., 2006) or similar activa-
tion (Xiao et al., 2012) in this region for the ASDs group compared to
that for the HC group during a go/no-go task. Thus, the SST load, as an
inhibition task, may be higher than that of the go/no-go task (Rubia
et al., 2001).
Furthermore, our previous study using NIRS during a go/no-go task
found that activation under the no-go condition was lower than that
under the go condition in the HC group (Nishimura et al., 2011), unlike
the results of the present study. Therefore, the pattern of activation ob-
served in the PFC during the SSTmay be different from that observed in
a go/no-go task. The present results for the SST showed that the ASDs
group might have a greater abnormality in the left VLPFC than the
ADHD group. This result is consistent with the ﬁndings of a neuropsy-
chological study reporting that childrenwith ASDs had amore profound
disability in inhibitory control than did children with ADHD (Corbett et
al., 2009). An fMRI study performed in children showed that the DLPFC
was signiﬁcantly less activated in boys with ADHD than in those with
ASDs during a sustained attention task (Christakou et al., 2012), which
is in contrast with the activation pattern observed here. This might be
because the task used in that study did not involve inhibitory controls.
The meaning of the [oxy-Hb] reascending observed in the left
VLPFC in the ADHD group during the post-SST period remains un-
clear. However, patients with schizophrenia also showed a similarly
robust [oxy-Hb] reascending during the post-task period of the VFT
in previous NIRS studies (Suto et al., 2004; Takizawa et al., 2008).
These results may be explained by a common dysfunction of the
monoamine system in ADHD and schizophrenia, as the repertoire
of ADHD-related genes resembles that of schizophrenia-related
genes (Williams et al., 2010b; Burbach, 2010). In the present study,
NIRS signal analyses that included the post-SST period distinguished
the ASDs and ADHD groups better (Fig. 5). The classiﬁcation accuracy
observed between the ASDs and ADHD groups using [oxy-Hb]
changes during the [SST + post-SST] period was also higher than
the accuracy obtained using [oxy-Hb] changes only during the SST
period. The high time resolution of NIRS enables detailed measure-
ments of time-course changes, thus providing important insights
into differences in inhibitory control during the SST between pa-
tients with ASDs and those with ADHD.
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Our results support the hypothesis that the ASDs group has lower
activation in a broad prefrontal area (Figs. 4 and 5) relative to the
HC group. The classiﬁcation accuracy obtained using [oxy-Hb] changes
between the ASDs and HC groups during both the SST and the [SST +
post-SST] period was highest in the channels for the left VLPFC. These
results are consistent with those of previous studies (Yamasaki et al.,
2010; Abell et al., 1999). A previous fMRI study showed that compared
to healthy adults, adults with ASDs had signiﬁcantly lower task-related
activation in the DLPFC during a spatial working memory task (Luna
et al., 2002; Ohnishi et al., 2000; Smith et al., 2004; Rinehart et al.,
2002). Further, compared to healthy children, children with autism
also showed reduced activation in the right DLPFC and VLPFC during a
novelty detection task (Gomot et al., 2006).
The fMRI study revealed that pre-SMA and PMA would show func-
tional interconnectivity via the basal ganglia circuitry to mediate re-
sponse execution or inhibition, whereas the VLPFC would inﬂuence
the basal ganglia circuitry via connectivity with pre-SMA (Duann et al.,
2009). The DLPFC, with its direct connections to the basal ganglia
(Alexander et al., 1986), is part of a distributed neural network
supporting the selection and suppression of motor responses (Garavan
et al., 2002). The fMRI study on ASDs children showed that when
using a go/no-go task, there was a signiﬁcant negative correlation be-
tween age and 2 right VLPFC correlation pairs: right VLPFC–bilateral
pre-SMA and right VLPFC–right caudate (Lee et al., 2009). Our study de-
tected a dysfunction in the neural basis of inhibition in adults with ASDs
in areas including the bilateral VLPFC, DLPFC, Pre-SMA, and PMA, when
compared to healthy controls using the NIRS, although it was difﬁcult to
detect a dysfunction of the basal ganglia.
As hypothesized, compared to the HC group, the ADHD group
showed underactivation of the right SMA, pre-SMA, and bilateral
DLPFC during the SST. The classiﬁcation accuracy obtained using [oxy-
Hb] changes between the ADHD and the HC group during both the
SST and the [SST + post-SST] period was highest in the channels for
the right pre-SMA and right PMA. These results are consistent with
those of previous studies on drug-naïve adult patients with ADHD
(Cubillo et al., 2010; Rubia et al., 2011), which used fMRI to show re-
duced activation in the right PFC during the SST. We also found that
the ADHD group had lesser activation than the HC group in the left
DLPFC,whichhas been directly implicated in attention switching in nor-
mal adults (Smith et al., 2004). A recent meta-analysis showed that pa-
tients with ADHD have consistent functional abnormalities in 2 distinct
domain-dissociated right hemispheric fronto-basal ganglia networks,
the VLPFC, supplementary motor area, and anterior cingulate cortex
for inhibition and the DLPFC, parietal, and cerebellar areas for attention
(Hart et al., 2013). Regarding cortical surface areas that NIRS couldmea-
sure, these results are consistent with our current study and a recent
NIRS study of adults with ADHD, which used the SST to show reduced
bilateral activation of the inferior frontal cortex in these individuals
compared to healthy adults (Schecklmann et al., 2013).
Our observation of decreased frontal activation during the SST was
in contrast to previous studies showing no abnormality of activation
in patients with ADHD during a go/no-go task (Dibbets et al., 2009;
Kooistra et al., 2010). This inconsistency may be related to task differ-
ences and MPH treatment history. Most of the patients included in
those 2 previous studies (Dibbets et al., 2009; Kooistra et al., 2010)
had been chronically medicated with MPH, and there is evidence of
long-term effects of MPH on brain structure (Shaw et al., 2009) and
brain function (Konrad et al., 2007).
4.3. Limitations
This study had several limitations. First, trying to differentiate two
behaviorally deﬁned psychiatric disorders by using biological markers
may not be the ﬁnal goal for the psychiatry, since the current diagnosticsystem is solely based on the categorization by behavior. Rather, future
psychiatry should pursue comprehensive recapturing of the association
between various dimensions of behavior and their biological basis. The
importance of identiﬁed biomarkers in the current study should be
interpreted in this context. For example, neuroimaging biomarkers
may be more useful in making decision on the use of a certain pharma-
cological intervention for an individual patient, compared with the be-
haviorally categorized diagnosis per se, which should be clariﬁed in
future studies. Second, only 6 patients underwent structured interviews
using the ADI-R, ADOS, and CAADID. Althoughwe included other partic-
ipants in this study only when at least 2 of the 3 trained child psychia-
trists had seen patients and given consistent diagnoses, the inter-rater
reliability for their evaluating psychiatrists was not established. Third,
our study focused on adult subjects; thus, it is unclear whether our
results can be extended to children with ASDs and ADHD. Fourth, the
application of our results in clinical practice requires the replication of
the ﬁndings in an independent sample. Fifth, the number of patients in-
cluded in the subsample (patients having ASDs with ADHD symptoms:
10 participants) was smaller than the optimal sample size for neuroim-
aging (Carter et al., 2008). However, we found a signiﬁcant difference
in prefrontal activation between patients having ASDs with ADHD
symptoms and those having ADHD. Although we also analyzed the cor-
relation between [oxy-Hb] changes during the task or the [task + post-
task] period and ASRS scores in addition to the analysis of this subsam-
ple using cut off score of ASRS, therewere no signiﬁcant correlations for
either the ASDs or the ADHD group. Finally, because subjects were
matched for IQ in each group and since IQ scores were relatively high,
participants in our study may not be representative of all general pa-
tients. It is necessary that our data be replicated in a larger sample of
participants.
4.4. Conclusions
In conclusion, the present study provides evidence of functional dif-
ferences in activation in the left VLPFC between drug-naïve patients
with ASDs and those with ADHD. Thus, the signal time course in the
left VLPFC may be a diagnostic marker for distinguishing ADHD from
ASDs. NIRS may be a candidate for an auxiliary diagnostic tool that is
useful for both clinicians and patients.
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